Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS‐STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast Cancer

Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comp...

Full description

Saved in:
Bibliographic Details
Published inAdvanced materials (Weinheim) Vol. 37; no. 4; p. e2406662
Main Authors Yuan, Haitao, Qiu, Chong, Wang, Xiaoxian, Wang, Peili, Yi, Letai, Peng, Xin, Xu, Xiaolong, Huang, Wei, Bai, Yunmeng, Wei, Jinxi, Ma, Jingbo, Wong, Yin Kwan, Fu, Chunjin, Xiao, Wei, Chen, Chunbo, Long, Ying, Li, Zhijie, Wang, Jigang
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.01.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor‐targeting photothermal therapy (PTT) to simultaneously tackle multiple immune‐suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT‐Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT‐mediated ICD effect and the transactivation of the cGAS‐STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT‐Mn Lipo NPs‐mediated PTT promoted M1 polarization of tumor‐associated macrophages, augmented T‐cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT‐Mn Lipo NPs‐based PTT with a checkpoint blockade therapy (anti‐PD‐1) can elicit long‐term immune memory besides tumor eradication. Collectively, this nano‐system can systemically activate antitumor immunity through STING activation and potentially establish long‐term memory against tumor recurrence.
AbstractList Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor‐targeting photothermal therapy (PTT) to simultaneously tackle multiple immune‐suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT‐Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT‐mediated ICD effect and the transactivation of the cGAS‐STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT‐Mn Lipo NPs‐mediated PTT promoted M1 polarization of tumor‐associated macrophages, augmented T‐cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT‐Mn Lipo NPs‐based PTT with a checkpoint blockade therapy (anti‐PD‐1) can elicit long‐term immune memory besides tumor eradication. Collectively, this nano‐system can systemically activate antitumor immunity through STING activation and potentially establish long‐term memory against tumor recurrence.
Triple-negative breast cancer has an immunologically "cold" microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor-targeting photothermal therapy (PTT) to simultaneously tackle multiple immune-suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT-Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT-mediated ICD effect and the transactivation of the cGAS-STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT-Mn Lipo NPs-mediated PTT promoted M1 polarization of tumor-associated macrophages, augmented T-cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT-Mn Lipo NPs-based PTT with a checkpoint blockade therapy (anti-PD-1) can elicit long-term immune memory besides tumor eradication. Collectively, this nano-system can systemically activate antitumor immunity through STING activation and potentially establish long-term memory against tumor recurrence.Triple-negative breast cancer has an immunologically "cold" microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor-targeting photothermal therapy (PTT) to simultaneously tackle multiple immune-suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT-Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT-mediated ICD effect and the transactivation of the cGAS-STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT-Mn Lipo NPs-mediated PTT promoted M1 polarization of tumor-associated macrophages, augmented T-cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT-Mn Lipo NPs-based PTT with a checkpoint blockade therapy (anti-PD-1) can elicit long-term immune memory besides tumor eradication. Collectively, this nano-system can systemically activate antitumor immunity through STING activation and potentially establish long-term memory against tumor recurrence.
Author Xu, Xiaolong
Chen, Chunbo
Li, Zhijie
Long, Ying
Wong, Yin Kwan
Bai, Yunmeng
Yuan, Haitao
Wang, Peili
Xiao, Wei
Yi, Letai
Fu, Chunjin
Wang, Xiaoxian
Ma, Jingbo
Wei, Jinxi
Qiu, Chong
Huang, Wei
Peng, Xin
Wang, Jigang
Author_xml – sequence: 1
  givenname: Haitao
  surname: Yuan
  fullname: Yuan, Haitao
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Center for Drug Research and Development Guangdong Provincial Key Laboratory of Advanced Drug Delivery System Guangdong Pharmaceutical University Guangzhou 510006 P. R. China
– sequence: 2
  givenname: Chong
  surname: Qiu
  fullname: Qiu, Chong
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing 100700 P. R. China
– sequence: 3
  givenname: Xiaoxian
  surname: Wang
  fullname: Wang, Xiaoxian
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China
– sequence: 4
  givenname: Peili
  surname: Wang
  fullname: Wang, Peili
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, National Clinical Research Center for Chinese Medicine Cardiology Xiyuan Hospital China Academy of Chinese Medical Sciences Beijing 100700 P. R. China
– sequence: 5
  givenname: Letai
  surname: Yi
  fullname: Yi, Letai
  organization: Inner Mongolia Medical University Hohhot Inner Mongolia 010000 P. R. China
– sequence: 6
  givenname: Xin
  surname: Peng
  fullname: Peng, Xin
  organization: Ningbo Municipal Hospital of TCM Affiliated Hospital of Zhejiang Chinese Medical University Ningbo 315010 P. R. China
– sequence: 7
  givenname: Xiaolong
  surname: Xu
  fullname: Xu, Xiaolong
  organization: Department of Critical Care Medicine Shenzhen People's Hospital The Second Clinical Medical College of Jinan University The First Affiliated Hospital of Southern University of Science and Technology Shenzhen 518020 P. R. China
– sequence: 8
  givenname: Wei
  surname: Huang
  fullname: Huang, Wei
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China
– sequence: 9
  givenname: Yunmeng
  surname: Bai
  fullname: Bai, Yunmeng
  organization: Department of Critical Care Medicine Shenzhen People's Hospital The Second Clinical Medical College of Jinan University The First Affiliated Hospital of Southern University of Science and Technology Shenzhen 518020 P. R. China
– sequence: 10
  givenname: Jinxi
  surname: Wei
  fullname: Wei, Jinxi
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China
– sequence: 11
  givenname: Jingbo
  surname: Ma
  fullname: Ma, Jingbo
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China
– sequence: 12
  givenname: Yin Kwan
  surname: Wong
  fullname: Wong, Yin Kwan
  organization: Department of Physiology Yong Loo Lin School of Medicine National University of Singapore Singapore 117600 Singapore
– sequence: 13
  givenname: Chunjin
  surname: Fu
  fullname: Fu, Chunjin
  organization: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing 100700 P. R. China
– sequence: 14
  givenname: Wei
  surname: Xiao
  fullname: Xiao, Wei
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Center for Drug Research and Development Guangdong Provincial Key Laboratory of Advanced Drug Delivery System Guangdong Pharmaceutical University Guangzhou 510006 P. R. China
– sequence: 15
  givenname: Chunbo
  surname: Chen
  fullname: Chen, Chunbo
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Department of Critical Care Medicine Shenzhen People's Hospital The Second Clinical Medical College of Jinan University The First Affiliated Hospital of Southern University of Science and Technology Shenzhen 518020 P. R. China
– sequence: 16
  givenname: Ying
  surname: Long
  fullname: Long, Ying
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China
– sequence: 17
  givenname: Zhijie
  surname: Li
  fullname: Li, Zhijie
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China
– sequence: 18
  givenname: Jigang
  orcidid: 0000-0002-0575-0105
  surname: Wang
  fullname: Wang, Jigang
  organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Center for Drug Research and Development Guangdong Provincial Key Laboratory of Advanced Drug Delivery System Guangdong Pharmaceutical University Guangzhou 510006 P. R. China, State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing 100700 P. R. China, State Key Laboratory of Antiviral Drugs School of Pharmacy Henan University Kaifeng 475004 P. R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39629527$$D View this record in MEDLINE/PubMed
BookMark eNpd0c1uEzEQB3ALFdG0cOWILHHhssEfu_b6GKIQKoVSkXBeee1JcLVrF9sLyo1H4AF4Op4ERy09cLJm_PPImv8FOvPBA0IvKZlTQthbbUc9Z4TVRAjBnqAZbRitaqKaMzQjijeVEnV7ji5SuiWEKEHEM3TOlWCqYXKGfq_8wXmA6PwBb2F0Jng7mXwqb8JwHMuNwdfaB30I3qWcSjuDz05nwGa92P75-Wu7u7pe4xudv_7QR7wor7_r7ILH2lu8GpxxGW9CmbiDOOKPMIZY2EE7nzL-DGaKEbwB7Dx-F0GX5lKXOj5HT_d6SPDi4bxEX96vdssP1ebT-mq52FSGyTZXXApr97yxLe2FUQ1oomTdS8laKpsGFJe2l4wDqD2vubV9r1upFDAwPeOaX6I393PvYvg2Qcrd6JKBYdAewpQ6TstCmaoFLfT1f_Q2TNGX3xUliGSkEaqoVw9q6kew3V10o47H7t_eC5jfAxNDShH2j4SS7hRsdwq2ewyW_wVCDJgO
Cites_doi 10.1016/j.apsb.2019.01.018
10.1002/anie.202315031
10.1016/j.apsb.2022.02.021
10.1021/jacs.2c09608
10.1021/acsnano.3c01404
10.1002/adma.202307115
10.1002/smll.202006970
10.1038/s41565-022-01225-x
10.1038/s41467-023-36878-2
10.1016/j.cej.2024.150364
10.1002/adfm.202313384
10.1002/advs.202309583
10.1021/jacs.2c12772
10.1038/s43018-022-00447-1
10.1021/jacs.2c03266
10.1038/s43018-020-0028-4
10.1002/advs.202401905
10.1021/jacs.3c11314
10.1016/j.chom.2017.06.013
10.1038/ncomms14392
10.1186/s12943-020-01247-w
10.1002/smll.202202161
10.1038/s41467-023-37825-x
10.1002/anie.202318539
10.1038/s43018-022-00468-w
10.1002/anie.201904751
10.1002/anie.202101924
10.1038/s41467-023-42883-2
10.1016/j.apsb.2021.11.005
10.1021/am508026s
10.1038/s41467-021-22572-8
10.1016/j.apsb.2023.08.015
10.1038/s41467-018-04703-w
10.1186/s40425-019-0811-x
10.1002/adfm.202307241
10.1021/acs.accounts.3c00394
ContentType Journal Article
Copyright 2024 Wiley‐VCH GmbH.
2025 Wiley‐VCH GmbH
Copyright_xml – notice: 2024 Wiley‐VCH GmbH.
– notice: 2025 Wiley‐VCH GmbH
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SR
8BQ
8FD
JG9
7X8
DOI 10.1002/adma.202406662
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Engineered Materials Abstracts
METADEX
Technology Research Database
Materials Research Database
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
METADEX
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Materials Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1521-4095
ExternalDocumentID 39629527
10_1002_adma_202406662
Genre Journal Article
GrantInformation_xml – fundername: Shenzhen Science and Technology Innovation Committee
  grantid: RCYX20221008092950121
– fundername: Scientific and technological innovation project of China Academy of Chinese Medical Sciences
  grantid: CI2023D008
– fundername: GuangDong Basic and Applied Basic Research Foundation
  grantid: 2021A1515012164
– fundername: International Science and Technology Cooperation for Shenzhen Technology Innovation Plan
  grantid: GJHZ20200731095411034
– fundername: National Natural Science Foundation of China
  grantid: 82070517
– fundername: CACMS Innovation Fund
  grantid: CI2023E002
– fundername: Shenzhen Fund for Guangdong Provincial High- level Clinical Key Specialties
  grantid: SZGSP001
– fundername: Central Public Welfare Research Institutes
  grantid: ZZ14-YQ-055
– fundername: National Natural Science Foundation of China
  grantid: 22407049
– fundername: Shenzhen Science and Technology Innovation Program
  grantid: JCYJ20210324114202008
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23M
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
6P2
6TJ
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
8WZ
930
A03
A6W
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYOK
AAYXX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADMLS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AETEA
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGYGG
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CITATION
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
EBS
EJD
F00
F01
F04
F5P
FEDTE
FOJGT
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6K
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NDZJH
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
RNS
ROL
RX1
RYL
SAMSI
SUPJJ
TN5
UB1
UPT
V2E
W8V
W99
WBKPD
WFSAM
WIB
WIH
WIK
WJL
WOHZO
WQJ
WTY
WXSBR
WYISQ
XG1
XPP
XV2
YR2
ZY4
ZZTAW
~02
~IA
~WT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7SR
8BQ
8FD
JG9
7X8
ID FETCH-LOGICAL-c278t-376ddf35d81b6c95ea0974b77281755e937db723ee9f343ddbba8799e2ecb23a3
ISSN 0935-9648
1521-4095
IngestDate Fri Jul 11 03:34:42 EDT 2025
Fri Jul 25 22:20:02 EDT 2025
Mon Jul 21 06:04:16 EDT 2025
Tue Jul 01 00:55:00 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords cGAS‐STING
semiconducting polymeric nanoagonists
elicit long term memory
immunogenic cell death
photothermal therapy
Language English
License 2024 Wiley‐VCH GmbH.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c278t-376ddf35d81b6c95ea0974b77281755e937db723ee9f343ddbba8799e2ecb23a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0575-0105
PMID 39629527
PQID 3160720569
PQPubID 2045203
ParticipantIDs proquest_miscellaneous_3140929461
proquest_journals_3160720569
pubmed_primary_39629527
crossref_primary_10_1002_adma_202406662
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Weinheim
PublicationTitle Advanced materials (Weinheim)
PublicationTitleAlternate Adv Mater
PublicationYear 2025
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_1_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – ident: e_1_2_8_17_1
  doi: 10.1016/j.apsb.2019.01.018
– ident: e_1_2_8_22_1
  doi: 10.1002/anie.202315031
– ident: e_1_2_8_15_1
  doi: 10.1016/j.apsb.2022.02.021
– ident: e_1_2_8_34_1
  doi: 10.1021/jacs.2c09608
– ident: e_1_2_8_28_1
  doi: 10.1021/acsnano.3c01404
– ident: e_1_2_8_16_1
  doi: 10.1002/adma.202307115
– ident: e_1_2_8_9_1
  doi: 10.1002/smll.202006970
– ident: e_1_2_8_32_1
  doi: 10.1038/s41565-022-01225-x
– ident: e_1_2_8_2_1
  doi: 10.1038/s41467-023-36878-2
– ident: e_1_2_8_8_1
  doi: 10.1016/j.cej.2024.150364
– ident: e_1_2_8_27_1
  doi: 10.1002/adfm.202313384
– ident: e_1_2_8_4_1
  doi: 10.1002/advs.202309583
– ident: e_1_2_8_13_1
  doi: 10.1021/jacs.2c12772
– ident: e_1_2_8_35_1
  doi: 10.1038/s43018-022-00447-1
– ident: e_1_2_8_29_1
  doi: 10.1021/jacs.2c03266
– ident: e_1_2_8_7_1
  doi: 10.1038/s43018-020-0028-4
– ident: e_1_2_8_26_1
  doi: 10.1002/advs.202401905
– ident: e_1_2_8_12_1
  doi: 10.1021/jacs.3c11314
– ident: e_1_2_8_31_1
  doi: 10.1016/j.chom.2017.06.013
– ident: e_1_2_8_18_1
  doi: 10.1038/ncomms14392
– ident: e_1_2_8_25_1
  doi: 10.1186/s12943-020-01247-w
– ident: e_1_2_8_21_1
  doi: 10.1002/smll.202202161
– ident: e_1_2_8_36_1
  doi: 10.1038/s41467-023-37825-x
– ident: e_1_2_8_11_1
  doi: 10.1002/anie.202318539
– ident: e_1_2_8_6_1
  doi: 10.1038/s43018-022-00468-w
– ident: e_1_2_8_23_1
  doi: 10.1002/anie.201904751
– ident: e_1_2_8_10_1
  doi: 10.1002/anie.202101924
– ident: e_1_2_8_3_1
  doi: 10.1038/s41467-023-42883-2
– ident: e_1_2_8_14_1
  doi: 10.1016/j.apsb.2021.11.005
– ident: e_1_2_8_20_1
  doi: 10.1021/am508026s
– ident: e_1_2_8_19_1
  doi: 10.1038/s41467-021-22572-8
– ident: e_1_2_8_30_1
  doi: 10.1016/j.apsb.2023.08.015
– ident: e_1_2_8_1_1
  doi: 10.1038/s41467-018-04703-w
– ident: e_1_2_8_33_1
  doi: 10.1186/s40425-019-0811-x
– ident: e_1_2_8_5_1
  doi: 10.1002/adfm.202307241
– ident: e_1_2_8_24_1
  doi: 10.1021/acs.accounts.3c00394
SSID ssj0009606
Score 2.4839525
Snippet Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator...
Triple-negative breast cancer has an immunologically "cold" microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage e2406662
SubjectTerms Animals
Breast cancer
Breast Neoplasms - immunology
Breast Neoplasms - pathology
Breast Neoplasms - therapy
Cell Line, Tumor
Female
Humans
Immune system
Immunotherapy
Interferon
Low temperature resistance
Macrophages
Membrane Proteins - metabolism
Mice
Nanoparticles - chemistry
Nucleotidyltransferases - metabolism
Polymers - chemistry
Semiconductors
Signal Transduction - drug effects
Stimulators
Tumor Microenvironment - drug effects
Title Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS‐STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/39629527
https://www.proquest.com/docview/3160720569
https://www.proquest.com/docview/3140929461
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLXKsIEF4k1hQEZCYhF1aB3n4WUZBioEqGI6oqwi23GHSCVBM4lgWPEJfAB_wR_xJdwbO4-iIg1sosZ1Hso9ts-9uTmXkEdjHXIdYVo51krlsfRHiuloFGplWGTCMU_rLN834eyIv1wGy8HgZy9rqSrVnv669buS_7EqtIFd8SvZf7Bse1JogN9gX9iChWF7Lhv3xARh0H8Eo-Yo34q782J9ZtPkYf4s5HGBCrmn0FxiehAQTE-_mB62qQ6HC4xazYEOfpZn3lQ3Rc_qdwsH60xnpfcKyxItYCb3XmN6LnQ7lhmwS6SetcqTrgVInmKae-ntI5xO-tx32qQbAEm2Twfp7TuT5R8M1nRuQxLvKxuVncmslEUbms0qmx9QuMW2fg1gp6plJosvPaA37XOTrbN-YIMFvcCGi1D6wUiEVohzz7j5maHLa-tyNhO4VY1xQOVb1wWrMyvTWmoKSUzo1oANAe4_FsY2XdFKO7MEj0_a4y-Qiwx8Eyyb8extp1mGLmEt8OjuvlEKHbMnm9ffZEJ_cW9qmrO4Sq44_4ROLdiukYHJr5PLPaDdID96e3QTdrSFHe3Djnawowi7X9--14CjDnC0AxwFwFELOIqAowg4agFHHeBoBzia5dQCjlrA3SRHzw8W-7ORK_Ix0iyKS1zg0nTlByn4T6EWgZFjcHEVPNgYmG1ggD6nKmK-MWLlcz9NlZJxJIRhRivmS_8W2cmL3NwhFJzzVKbAuFZ8whUXsUE6a6D_RPGJCIbkcfPAk09WyyXZbtoh2W3skbjxfpr4qMXIwGEQQ_Kw_RtmY3zFJnNTVNgHwMkEDydDctvasb2UL0ImAhbdPfdt3COXuoGxS3bKk8rcBw5cqgc15n4DR2qztA
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Engineering+Semiconducting+Polymeric+Nanoagonists+Potentiate+cGAS%E2%80%90STING+Pathway+Activation+and+Elicit+Long+Term+Memory+Against+Recurrence+in+Breast+Cancer&rft.jtitle=Advanced+materials+%28Weinheim%29&rft.au=Yuan%2C+Haitao&rft.au=Qiu%2C+Chong&rft.au=Wang%2C+Xiaoxian&rft.au=Wang%2C+Peili&rft.date=2025-01-01&rft.issn=0935-9648&rft.eissn=1521-4095&rft.volume=37&rft.issue=4&rft_id=info:doi/10.1002%2Fadma.202406662&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_adma_202406662
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0935-9648&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0935-9648&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0935-9648&client=summon